over the counter glp-1 agonists Nature Made Companion Health Pack, 30 *Based on a 2024 survey of pharmacists who recommend branded vitamins and supplements Let me ask you what

Research, including recent findings from the SELECT trial, indicates that GLP-1 agonists like semaglutide can significantly reduce the risk of major cardiovascular events, such as heart attacks and strokes, especially in individuals with obesity but without diabetes

42) In SUSTAIN-6, patients treated with semaglutide had a lower risk of developing or worsening nephropathy, but a higher risk of complications from diabetic retinopathy than those receiving placebo (40)

The functions are illustrated in the Figure ( Figure 4 )

GLP-1 drugs blunt that dopamine response

Bear in mind that these drugs are not a first-line defense against mild weight gain

[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Meurot C, et al